Glucagon-Like Peptide-1 Receptor Agonist and the Risk of Pulmonary Aspiration: An Update on Current Recommendations and the Utility of Gastric Ultrasound-Glucagon-Like Peptid-1 Receptor Agonist and the Risk of Pulmonary Aspiration

Video Transcription

Video Summary

Rhea Temmerman opens the 2024 Hybrid Annual Congress, providing essential announcements about the ANA Meetings app for schedule details, speaker bios, session handouts, and claiming CE credits. She stresses the importance of completing evaluations promptly.<br /><br />Dr. Amy Reed then presents on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in anesthesia, focusing on their role in treating type 2 diabetes while also aiding weight loss. These medications delay gastric emptying, raising concerns about pulmonary aspiration during anesthesia. Reed outlines the physiology of insulin resistance and the function of exogenous GLP-1s, which mimic natural incretin hormones but resist enzymatic degradation.<br /><br />The session delves into the significant use and impact of GLP-1 RAs in healthcare and society, touching on their economic demands and risks, such as gut paralysis and hypoglycemia. Current literature advises holding these medications preoperatively and using gastric ultrasound to evaluate gastric content, referring patients to endocrinologists when necessary. Reed describes the technical approach to gastric ultrasound, including positioning and probe settings, and the qualitative and quantitative assessment of gastric contents.<br /><br />Live gastric ultrasound demonstrations follow, involving volunteers, showcasing the ease of identifying stomach content states. Reed emphasizes the necessity for ongoing training and practice in gastric ultrasound, underscoring its growing importance in anesthesia care.

Keywords

Hybrid Annual Congress

ANA Meetings app

GLP-1 receptor agonists

type 2 diabetes

gastric emptying

pulmonary aspiration

gastric ultrasound

insulin resistance

anesthesia care